Axplora
Sylke Hassel is an accomplished executive with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as Chief Executive Officer at Axplora since October 2022, Sylke has held CEO positions at Novasep and PharmaZell Group, as well as leadership roles at Lonza, Sandoz International GmbH, and McKinsey. Sylke's educational background includes a Master of Science in Biology/Biochemistry from The Julius Maximilians University of Würzburg, where the focus was on cell biology, virology, and immunology. Sylke's career reflects a strong commitment to advancing biopharmaceutical innovation and strategy.
Axplora
A premier API manufacturing partner to the world’s leading patient-centric pharmaceutical and biotechnology companies, delivering top quality active ingredients on time and at scale, to the highest industry standards. Axplora is dedicated to helping pharmaceutical companies make critical medicines better, faster, safely, reliably, and sustainably benefitting patients worldwide.